Alector Inc
SWB:0Z2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alector Inc
SWB:0Z2
|
US |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
M
|
Meltronix Inc
OTC:MTNX
|
US |
|
C
|
Catalyst Bancorp Inc
NASDAQ:CLST
|
US |
|
L
|
Likewise Group PLC
LSE:LIKE
|
UK |
|
V
|
Vestas Wind Systems A/S
XMUN:VWSB
|
DK |
Intrinsic Value
Is 0Z2 undervalued or overvalued?
See the intrinsic value estimate for 
Alector Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Alector Does
Alector Inc. is a clinical-stage biotechnology company working on medicines for brain diseases such as Alzheimer’s and frontotemporal dementia. Its idea is to use the body’s immune system, especially cells in the brain called microglia, to help clear harmful proteins and slow disease progression. The company does not sell approved drugs itself; it develops drug candidates and tests them in clinical trials.
- Headquarters
- United States of America US
- Employees
- 103
- IPO date
- Feb 7, 2019
Revenue & Expenses Breakdown
Alector Inc
Earnings Waterfall
Alector Inc
The intrinsic value for Alector Inc (0Z2) under the Base Case is hidden EUR.
Compared with the current market price of 1.444 EUR, the stock appears hidden.